RXST Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
33.7M
+9.2%
30.9M
-5.3%
32.6M
+7.5%
30.3M
-9.8%
33.6M
Cost of Revenue
7.9M
+6.2%
7.4M
+0.7%
7.3M
+20.2%
6.1M
-27.6%
8.4M
Gross Profit
25.9M
+10.2%
23.5M
-7.0%
25.3M
+4.3%
24.2M
-3.8%
25.2M
Operating Expenses
39.7M
-4.0%
41.3M
+12.9%
36.6M
+0.5%
36.4M
-7.1%
39.2M
R&D
9.2M
-2.5%
9.5M
+6.4%
8.9M
-1.7%
9.1M
-11.3%
10.2M
SG&A
30.4M
-4.5%
31.9M
+15.0%
27.7M
+1.3%
27.3M
-5.6%
29.0M
Operating Income
-13770000
+22.8%
-17829000
-57.3%
-11337000
+6.9%
-12178000
+13.0%
-14003000
EBITDA
-12771000
+24.9%
-16995000
-62.1%
-10486000
+7.4%
-11324000
+14.3%
-13218000
Net Income
-12097000
+23.8%
-15884000
-73.6%
-9152000
+6.8%
-9816000
+16.7%
-11786000
EPS (Basic)
$-0.29
+23.7%
$-0.38
-72.7%
$-0.22
+8.3%
$-0.24
+17.2%
$-0.29
EPS (Diluted)
$-0.29
+23.7%
$-0.38
-72.7%
$-0.22
+8.3%
$-0.24
+17.2%
$-0.29
Shares (Diluted)
41.5M
+0.4%
41.3M
+0.3%
41.2M
+0.5%
41.0M
+0.5%
40.7M
RxSight (RXST) โ€” Financials